Aberdeen Group plc lessened its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 0.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,127,250 shares of the real estate investment trust's stock after selling 8,017 shares during the quarter. Aberdeen Group plc owned 0.39% of Omega Healthcare Investors worth $43,145,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. Raymond James Financial Inc. bought a new position in Omega Healthcare Investors during the 4th quarter worth about $20,058,000. Mariner LLC increased its stake in Omega Healthcare Investors by 1.9% in the fourth quarter. Mariner LLC now owns 171,617 shares of the real estate investment trust's stock valued at $6,496,000 after acquiring an additional 3,186 shares during the last quarter. NewEdge Advisors LLC grew its stake in shares of Omega Healthcare Investors by 21.5% in the fourth quarter. NewEdge Advisors LLC now owns 29,565 shares of the real estate investment trust's stock worth $1,119,000 after purchasing an additional 5,240 shares during the last quarter. Farringdon Capital Ltd. acquired a new position in shares of Omega Healthcare Investors during the fourth quarter valued at about $243,000. Finally, CANADA LIFE ASSURANCE Co raised its holdings in shares of Omega Healthcare Investors by 6.4% in the 4th quarter. CANADA LIFE ASSURANCE Co now owns 530,602 shares of the real estate investment trust's stock worth $20,083,000 after acquiring an additional 31,860 shares during the last quarter. Institutional investors and hedge funds own 65.25% of the company's stock.
Insider Transactions at Omega Healthcare Investors
In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the sale, the director directly owned 18,654 shares in the company, valued at $749,144.64. This represents a 11.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.50% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
A number of analysts recently commented on OHI shares. Wells Fargo & Company upgraded shares of Omega Healthcare Investors from an "equal weight" rating to an "overweight" rating and upped their price target for the company from $38.00 to $41.00 in a research note on Monday, July 14th. Royal Bank Of Canada raised their price target on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a report on Thursday, August 7th. Four research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $42.00.
Get Our Latest Stock Analysis on Omega Healthcare Investors
Omega Healthcare Investors Stock Performance
Omega Healthcare Investors stock traded up $0.14 during mid-day trading on Friday, reaching $42.50. 432,660 shares of the company traded hands, compared to its average volume of 2,395,661. The firm's fifty day moving average is $38.40 and its two-hundred day moving average is $37.58. The company has a market capitalization of $12.54 billion, a price-to-earnings ratio of 26.28, a price-to-earnings-growth ratio of 2.22 and a beta of 0.66. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10. Omega Healthcare Investors, Inc. has a fifty-two week low of $35.04 and a fifty-two week high of $44.42.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The firm had revenue of $235.60 million during the quarter, compared to analysts' expectations of $248.49 million. During the same quarter last year, the company posted $0.71 earnings per share. The firm's revenue was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, equities research analysts expect that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.
Omega Healthcare Investors Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were issued a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 6.3%. The ex-dividend date of this dividend was Monday, August 4th. Omega Healthcare Investors's dividend payout ratio (DPR) is presently 165.43%.
Omega Healthcare Investors Profile
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
See Also

Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.